FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308103600> ?p ?o ?g. }

• W4308103600 abstract "Inflammatory bowel disease (IBD) is a chronic relapsing inflammation of the intestinal tract with currently not well-understood pathogenesis. In addition to the involvement of immune cells, increasing studies show an important role for fibroblasts in the pathogenesis of IBD. Previous work showed that glycolysis is the preferred energy source for fibroblasts in fibrotic diseases. 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 3 (PFKFB3) is a key kinase supporting glycolysis. Increased expression of PFKFB3 in several cancers and inflammatory diseases has been previously reported, but the metabolic status of fibroblasts and the role of PFKFB3 in patients with IBD are currently unknown. Therefore, in this study, we evaluated the role of glycolysis and PFKFB3 expression in IBD. Single-sample gene set enrichment analysis (ssGSEA) revealed that glycolysis was significantly higher in IBD intestinal samples, compared to healthy controls, which was confirmed in the validation cohorts of IBD patients. Single-cell sequencing data indicated that PFKFB3 expression was higher in IBD-derived stromal cells. In vitro, PFKFB3 expression in IBD-derived fibroblasts was increased after the stimulation with pro-inflammatory cytokines. Using seahorse real-time cell metabolic analysis, inflamed fibroblasts were shown to have a higher extracellular acidification rate and a lower oxygen consumption rate, which could be reversed by inhibition of JAK/STAT pathway. Furthermore, increased expression of pro-inflammatory cytokines and chemokines in fibroblasts could be reverted by PFK15, a specific inhibitor of PFKFB3. In vivo experiments showed that PFK15 reduced the severity of dextran sulfate sodium (DSS)- and Tcell transfer induced colitis, which was accompanied by a reduction in immune cell infiltration in the intestines. These findings suggest that increased stromal PFKFB3 expression contributes to inflammation and the pathological function of fibroblasts in IBD. Inhibition of PFKFB3 suppressed their inflammatory characteristics." @default.
• W4308103600 created "2022-11-08" @default.
• W4308103600 creator A5026624461 @default.
• W4308103600 creator A5031343879 @default.
• W4308103600 creator A5034558789 @default.
• W4308103600 creator A5042669238 @default.
• W4308103600 creator A5044948964 @default.
• W4308103600 creator A5045278934 @default.
• W4308103600 creator A5072231061 @default.
• W4308103600 creator A5082088297 @default.
• W4308103600 creator A5090541830 @default.
• W4308103600 date "2022-11-02" @default.
• W4308103600 modified "2023-10-01" @default.
• W4308103600 title "Increased stromal PFKFB3-mediated glycolysis in inflammatory bowel disease contributes to intestinal inflammation" @default.
• W4308103600 cites W1596258860 @default.
• W4308103600 cites W1793883704 @default.
• W4308103600 cites W1966107523 @default.
• W4308103600 cites W1984119315 @default.
• W4308103600 cites W1986079650 @default.
• W4308103600 cites W1986775143 @default.
• W4308103600 cites W1990253071 @default.
• W4308103600 cites W1991261802 @default.
• W4308103600 cites W2004608617 @default.
• W4308103600 cites W2005959793 @default.
• W4308103600 cites W2035612098 @default.
• W4308103600 cites W2042149494 @default.
• W4308103600 cites W2045142779 @default.
• W4308103600 cites W2054149870 @default.
• W4308103600 cites W2054828149 @default.
• W4308103600 cites W2060373663 @default.
• W4308103600 cites W2064428337 @default.
• W4308103600 cites W2069089843 @default.
• W4308103600 cites W2072703892 @default.
• W4308103600 cites W2073686450 @default.
• W4308103600 cites W2082884465 @default.
• W4308103600 cites W2106223802 @default.
• W4308103600 cites W2125733720 @default.
• W4308103600 cites W2128771042 @default.
• W4308103600 cites W2151734278 @default.
• W4308103600 cites W2162873738 @default.
• W4308103600 cites W2166839330 @default.
• W4308103600 cites W2396058978 @default.
• W4308103600 cites W2460126719 @default.
• W4308103600 cites W2472794893 @default.
• W4308103600 cites W2525561198 @default.
• W4308103600 cites W2529705542 @default.
• W4308103600 cites W2580798654 @default.
• W4308103600 cites W2591251590 @default.
• W4308103600 cites W2591655379 @default.
• W4308103600 cites W2606862055 @default.
• W4308103600 cites W2736855264 @default.
• W4308103600 cites W2753317696 @default.
• W4308103600 cites W2769148407 @default.
• W4308103600 cites W2774359923 @default.
• W4308103600 cites W2775970241 @default.
• W4308103600 cites W2783965079 @default.
• W4308103600 cites W2790513522 @default.
• W4308103600 cites W2791100873 @default.
• W4308103600 cites W2794921186 @default.
• W4308103600 cites W2803017775 @default.
• W4308103600 cites W2803660147 @default.
• W4308103600 cites W2807347951 @default.
• W4308103600 cites W2876613972 @default.
• W4308103600 cites W2889244860 @default.
• W4308103600 cites W2890935099 @default.
• W4308103600 cites W2894232765 @default.
• W4308103600 cites W2902949106 @default.
• W4308103600 cites W2904920374 @default.
• W4308103600 cites W2919709190 @default.
• W4308103600 cites W2921362378 @default.
• W4308103600 cites W2922895641 @default.
• W4308103600 cites W2936501646 @default.
• W4308103600 cites W2944766235 @default.
• W4308103600 cites W2947882120 @default.
• W4308103600 cites W2970463661 @default.
• W4308103600 cites W2980256748 @default.
• W4308103600 cites W3009569400 @default.
• W4308103600 cites W3011813642 @default.
• W4308103600 cites W3012799117 @default.
• W4308103600 cites W3033653334 @default.
• W4308103600 cites W3080380488 @default.
• W4308103600 cites W3104558320 @default.
• W4308103600 cites W3108087034 @default.
• W4308103600 cites W3201475508 @default.
• W4308103600 cites W3202085412 @default.
• W4308103600 cites W3205008568 @default.
• W4308103600 cites W4210410309 @default.
• W4308103600 cites W4210412154 @default.
• W4308103600 cites W4220660249 @default.
• W4308103600 cites W4292371019 @default.
• W4308103600 doi "https://doi.org/10.3389/fimmu.2022.966067" @default.
• W4308103600 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36405760" @default.
• W4308103600 hasPublicationYear "2022" @default.
• W4308103600 type Work @default.
• W4308103600 citedByCount "5" @default.
• W4308103600 countsByYear W43081036002023 @default.
• W4308103600 crossrefType "journal-article" @default.
• W4308103600 hasAuthorship W4308103600A5026624461 @default.
• W4308103600 hasAuthorship W4308103600A5031343879 @default.
• W4308103600 hasAuthorship W4308103600A5034558789 @default.

• next